alaeloa,
sure, that may apply elsewhere but it's not what is going on here. Do you really think that ACT Management would file an 8K today disclosing the following(see below) if any of your scenarios were true? ACT just settled with Midsummer Investments(66 million shares) for the same price resets the current Alpha lawsuit is for..Prior to that we settled with Gemini for about 21MM shares. Bristol won their lawsuit last year for 50MM shares. at .02 pps...Alpha won a prior suit in 2009 for 7.5MM shares. To my knowledge, no lawsuit has ever been "thrown out" for any reason. Hopefully our luck will change but to date ACT has not won a case so their track record is zero. Maybe this time around will be different but to not take them seriously is a huge mistake...
(todays 8k filing by ACT)
Item 8.01 Other Events
On or about September 16, 2011, Alpha Capital Anstalt, a Liechtenstein corporation with its principal place of business in Vaduz, Liechtenstein (“plaintiff”), filed an action against Advanced Cell Technology, Inc. (the “Company”) in the United States District Court for the Southern District of New York, Case No. 11 CIV 6458. Plaintiff alleges that it is or was a holder of various convertible notes and warrants issued by the Company, and that by reason of certain transactions between the Company and JMJ Financial, Inc. during 2010, the exercise and conversion prices in plaintiff’s convertible notes and warrants should have been reset. Plaintiff demands a preliminary and permanent injunction directing that the Company deliver to it at least 39,514,859 shares of its common stock, as well as monetary damages in an amount to be determined at trial. The Company intends to defend against this action vigorously.
Although not currently named as plaintiffs in this or other actions against the Company, in the event all other holders of convertible notes and warrants issued by the Company similarly situated to plaintiff were to file substantially similar actions based upon substantially similar claims and allegations, the Company estimates that the number of shares of common stock such holders of convertible notes could demand would be approximately 8 million, and the number of additional warrants convertible into shares of common stock such holders of warrants could demand would be approximately 380 million. The total number of shares of common stock of the Company currently outstanding is in excess of 1.62 billion.